Trial Design Articles

May 04, 2015
Applied Clinical Trials
TransCelerate recently launched the Placebo and Standard of Care Data Sharing Initiative in order to foster a data sharing infrastructure between TransCelerate member companies.
Apr 29, 2015
Applied Clinical Trials
Aspects of brain health include the way we think, feel, play, work, recall information and sleep. Exercise, healthy eating and positive social interactions are already known to improve these aspects of brain health, as are continually exercising the cognitive abilities of our brains.
Mar 31, 2015
Applied Clinical Trials
How the practical application of these methods can help overcome the complex demands of cancer trials.
Mar 31, 2015
Applied Clinical Trials
Successful conduct of hematological malignancy trials requires addressing several unique complexities.
Mar 31, 2015
Applied Clinical Trials
Study shows that industry contributions to R&D go well beyond the applied area of clinical testing.
Feb 01, 2015
Applied Clinical Trials
New study highlights the importance of focusing on non-core procedures to better optimize study design.
Feb 01, 2015
Applied Clinical Trials
Cancer Research UK applies risk-based monitoring across its entire trial portfolio. What were the results?
Feb 01, 2015
Applied Clinical Trials
Examining the design, implementation, and challenges of this direct-to-patient study model.
Jan 22, 2015
Applied Clinical Trials
Over recent years global drug companies large or small have recognized that one root cause of the high failure rate in their clinical development lies in the selection of right therapeutic targets.
Jan 19, 2015
Applied Clinical Trials
Case Study, Trigemina TI-001 for high frequency migraine

Trial Design News

inVentiv Health Expands Global Regulatory Compliance Services

inVentiv Health, a global provider of clinical development and comprehensive commercialization services, announced expansion of compliance products and services to assist biopharmaceutical companies conducting non-interventional studies globally.

Quotient Clinical Completes Enabled FIH Program

Quotient Clinical has announced results from an Enabled-First-in-Human (Enabled-FIH) program conducted for the Janssen WAVE Early Development unit.

YPrime Awarded Global Phase II Oncology Clinical Trial

Throughout this trial, YPrime will be supporting world class selected sites to conduct the study with data driven metrics pulled from these tools. YPrime is dedicated to applying its leading edge eClinical technology to help forward unmet medical needs in the Biotech and Pharmaceutical industry.

Annual ASCO Report Shows Widespread Disturbance in Oncology Practice

A new study by the American Society of Clinical Oncology (ASCO) is now available, which chronicles the current realities of the cancer care system and examines trends in the oncology workforce.

CRF Health's eCOA Solution for Diabetes Trials

CRF Health, the leading global provider of eCOA solutions for the life sciences industry, today announced a complete TrialMax® eCOA solution for diabetes clinical trials.